Vanda Pharmaceuticals Inc.

US$3.82As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:VNDAHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (12.67%)
Div yield —
ROE (82.55%)
Biotechnology
Beta (5Y) 0.73
PE TTM —
TSR TTM (12.18%)
Mkt cap US$231.0M
ROIC (230.56%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.81
(0.27%)
(25.03%)
Hold 6|5|5|4|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.05
0.04
9.82%
25.13%
36.66%
25.78%
Revenue$M
10.54
11.13
11.79
11.53
3.84%
4.95%
11.98%
8.74%
Peers (US$231.0M)
Cap (US$)
PE
230.0M
—
Capital
TTM
5Y
10Y
Leveragex
2.369
1.675
1.192
EBIT/Intx
0.052
1.989
1.723
Own earn%
(60.16)
8.06
12.56
Sh yield%
41.37
41.67
42.66
Owners
Insiders/Inst%
2.78
49.82
Short interest%
5.37
SBC / revenue%
2.90
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
25–38
$1 testx
0.0
Incr. ROIC%
0